№ files_lp_4_process_2_54421
Formal record of the appeal hearing considering challenges to NICE’s guidance on fenfluramine for managing seizures in Lennox–Gastaut syndrome, detailing participant statements, grounds of appeal, and procedural deliberations.
Year: 2024
Organization: National Institute for Health and Care Excellence (NICE)
Document type: Appeal hearing decision
Subject: Fenfluramine treatment for Lennox–Gastaut syndrome
Participants: UCB Pharma, Royal College of Physicians, Tuberous Sclerosis Association, NICE appraisal committee
Location: United Kingdom
Target audience: NHS, healthcare professionals, stakeholders involved in rare epilepsy treatment
Hearing date: 6 September 2024
Panel chair: Professor Jon Cohen
Legal adviser: Amy Smith, DAC Beachcroft LLP
Evaluation scope: Assessment of clinical and cost effectiveness for fenfluramine in patients aged 2 years and older
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.